2026 Guidelines for the Early Detection of Prostate Cancer - what are the recommendations and what does it mean going forward for GPs and their patients?

Join our specialist panel as they discuss the recently launched Clinical Practice Guidelines for the Early Detection of Prostate Cancer, new recommendations into practice and the impact of these changes for general practitioners and their patients. Our panel will also review the current imaging modalities for prostate cancer.

A case-based discussion will cover topics including risk factors for prostate cancer, different cancer risk categories, when to refer, imaging and biopsy.

Specialist Panel

Dr Jane Crowe, Prostate Cancer GP and Moderator

Mr Phil Dundee, Urological Surgeon

Learning outcomes:

By the end of this activity, participants will be able to:

1. Discuss the key recommendations for the early detection of prostate cancer testing as per the 2026 Clinical Practice Guidelines.

2. Recognise the role of PSA screening and imaging in the early detection of prostate cancer.